Speeches by Hoare.

“My questions are to Mr Reland and Dr Whitten. The Northern Ireland Secretary, as we know, recently reiterated the Government’s manifesto commitment to upholding and protecting the UK internal market and, alongside that, preventing new regulatory barriers between Northern Ireland and the other parts of the UK. We would …”

“Is it your assessment, on the basis of where there’s a will there’s a way, that if there is a need for a product, whatever the product might be, it would be available should need be there, as long as the certificate requirements are met?”

“Thank you.”

“You win the prize for shortest answer, which is usually the most well received.”

“Would responsibility for that certificate rest with the veterinary surgeon to secure or with the producer in the pharmaceutical sector?”

“Yes, indeed. Is it your assessment that there is no other legitimate route—I underscore the word “legitimate”—to secure access to these treatments?”

“Where are we on access to the usual medicines that a vet will prescribe to a pet owner on a daily basis, in terms of percentages and figures?”

“Are you able to give us some indication of percentage? What is your level of concern about certain medicines and treatments from the pharmaceutical sector that will not be or would not be available?”

“Good morning, Dr Dunbar. Business obviously wants to sell its product, and many have demonstrated in recent times considerable agility in meeting the new tests and challenges. Could you talk us through your understanding of the adjustments which have already been made by the pharmaceutical industry itself, to ensure co…”

“Is that a yes or a no?”

“Thank you.”

“Is that a yes or a no?”

“You win the prize for shortest answer, which is usually the most well received.”

“Good morning, Dr Dunbar. Business obviously wants to sell its product, and many have demonstrated in recent times considerable agility in meeting the new tests and challenges. Could you talk us through your understanding of the adjustments which have already been made by the pharmaceutical industry itself, to ensure co…”

“Are you able to give us some indication of percentage? What is your level of concern about certain medicines and treatments from the pharmaceutical sector that will not be or would not be available?”

“Where are we on access to the usual medicines that a vet will prescribe to a pet owner on a daily basis, in terms of percentages and figures?”

“Yes, indeed. Is it your assessment that there is no other legitimate route—I underscore the word “legitimate”—to secure access to these treatments?”

“Would responsibility for that certificate rest with the veterinary surgeon to secure or with the producer in the pharmaceutical sector?”

“I want to draw out all three of you on this point, which may help this Committee when it makes recommendations to Government in its report following this inquiry. For too many people, Brexit was seen as an event rather than a process to be implemented over time, with different events that would occur and would need to …”

“I was not asking you, Mr Robinson.”